Intellectual property diligence for high-stakes decisions.

When real capital is at risk, a patent portfolio is only as valuable as it is defensible. We help investors, acquirers, and strategic buyers understand what they are actually buying.

Many patent attorneys ignore the transaction market.

For medical, AI-enabled, and advanced technology targets, the hardest diligence questions are technical: Does the portfolio actually cover the product? Are the claims valid over the real prior art? Is there freedom to operate? A reviewer fluent in the domain answers those questions with far more confidence.

Who We Support

Diligence built for the people writing the check.

Investors

Venture and growth investors assessing IP strength before and between financing rounds.

Acquirers

Strategic and corporate acquirers integrating technology and portfolios into existing programs.

Private Equity

Sponsors underwriting technology-driven targets and platform investments.

Strategic Buyers

Operating companies acquiring capabilities, products, or defensive IP positions.

Scope of Review

What a diligence engagement examines.

Portfolio coverage versus the actual product and roadmap
Claim scope, strength, and likely enforceability
Validity exposure over real-world prior art
Freedom-to-operate and third-party infringement risk
Chain of title, inventorship, and assignment integrity
Prosecution history and outstanding deadlines
Competitive landscape and design-around risk

Engage for a Transaction

Bring technical depth to your next diligence.

Schedule a confidential consultation to discuss the target technology, timeline, and scope of review.

Request a Confidential Consultation